Hanmi Pharmaceutical., Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanmi Pharmaceutical., Company Limited with three other
companies in this sector in South Korea:
Daewoong Company Limited
sales of 1.12 trillion Korean Won [US$1.05 billion]
of which 113%
was Medicinal Manufacturing & Selling),
Kwang Dong Pharmaceutical Company Limited
(1.14 trillion Korean Won [US$1.07 billion]
of which 40%
was MRO), and
Daewoong Pharmaceutical Company Limited
(960.31 billion Korean Won [US$896.93 million]
of which 101%
was Medicine Manufacture&Sale).
Hanmi Pharmaceutical., Company Limited reported sales of 916.59 billion Korean Won (US$856.09 million)
December of 2017.
increase of 3.8%
versus 2016, when the company's sales were 882.72 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2015, when Hanmi Pharmaceutical., Company Limited
reported sales of 1.32 trillion Korean Won.
Sales of Overseas Medicine saw an increase
that was more than double the company's growth rate: sales were up
11.1% in 2017, from
192.45 billion Korean Won to 213.90 billion Korean Won.
Not all segments of Hanmi Pharmaceutical., Company Limited experienced an increase in sales in 2017:
sales of Raw Medicine fell 30.1% to 5.89 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).